Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Peptidisc-Assisted Nanobody Multimerization: Expanding Prote
2026-07-29
Chen and Duong van Hoa introduce a peptidisc-based method for assembling multimeric and multispecific nanobody complexes, termed polybodies. This strategy leverages hydrophobic clustering stabilized by peptidiscs, enhancing stability and functionality in nanobody engineering and offering a detergent-free alternative to existing multimerization approaches.
-
PYR-41: Applied Workflows for Ubiquitin-Activating Enzyme E1
2026-07-29
PYR-41, a selective inhibitor of Ubiquitin-Activating Enzyme E1, empowers researchers to dissect ubiquitin-proteasome system dynamics in real time. This guide details optimized workflows, advanced troubleshooting, and unique assay choices for translational inflammation and virology models.
-
PF-573228: FAK Inhibitor Workflows for Mechanotransduction &
2026-07-28
PF-573228, a gold-standard FAK inhibitor from APExBIO, empowers researchers to dissect how substrate stiffness and cell adhesion cues drive signaling in cancer and tissue engineering. This guide covers actionable protocols, troubleshooting, and advanced applications, bridging recent mechanotransduction breakthroughs with robust experimental design.
-
AMPK Suppresses Autophagy: Revisiting Energy Stress Response
2026-07-28
This study overturns the prevailing model by demonstrating that AMPK, rather than universally inducing autophagy, actively suppresses the autophagy-initiating kinase ULK1 during energy stress. These findings reshape our understanding of energy metabolism regulation and have significant implications for experimental approaches in metabolic and autophagy research.
-
Nifedipine (BAY-a-1040) in Calcium Influx and Liver Regenera
2026-07-27
Nifedipine (BAY-a-1040) is a precision L-type calcium channel blocker enabling advanced studies of calcium-dependent signaling, iron metabolism, and fungal pathogenesis. This article unpacks stepwise experimental workflows, highlights protocol nuances, and contextualizes Nifedipine within the expanding landscape of liver regeneration and drug metabolism models.
-
Silver Nanoparticles Trigger Ferroptosis-Mediated Liver Infl
2026-07-27
This study elucidates how silver nanoparticles (AgNPs) induce liver inflammation in zebrafish through ferroptosis, identifying key genes involved and linking the process to glucose metabolism disruption. The findings advance mechanistic understanding of nanomaterial-induced hepatotoxicity and inform toxicological risk assessment strategies.
-
Protein A/G Magnetic Beads: Protocols and Best Practices
2026-07-26
Protein A/G Magnetic Beads (SKU K1305) enable high-specificity antibody isolation and protein-protein interaction studies in complex biological samples. These beads are ideal for immunoprecipitation, co-immunoprecipitation, and chromatin immunoprecipitation (Ch-IP) workflows where non-specific binding is a concern. They are not suitable for diagnostic or clinical applications.
-
Modeling HSV-1 Latency in Human iPSC-Derived Sensory Neurons
2026-07-25
This study establishes a scalable in vitro system for HSV-1 latency and reactivation using human iPSC-derived sensory neurons, overcoming previous limitations of animal-derived models. The approach enables detailed investigation into the neuron-intrinsic mechanisms governing herpesvirus latency and offers a human-relevant platform for testing potential interventions.
-
Viral Control of RIPK3 Degradation Shapes Host Inflammatory
2026-07-24
This study uncovers a class of viral proteins that induce degradation of the necroptosis adaptor RIPK3, allowing orthopoxviruses such as cowpox virus to suppress host inflammatory cell death. The findings reveal how targeted manipulation of ubiquitin pathways by viruses regulates inflammation and pathogenesis, with implications for future antiviral and immunology research.
-
Viral Induction of RIPK3 Degradation Modulates Necroptosis
2026-07-24
Liu et al. identified a class of orthopoxvirus proteins that induce targeted degradation of RIPK3, thereby suppressing necroptosis and modulating virus-induced inflammation. This mechanistic insight advances our understanding of host-pathogen interactions and highlights the central role of the ubiquitin-proteasome system in regulating antiviral immune responses.
-
Gramine Induces Ferroptosis via CUL3–MTDH Axis in TNBC Model
2026-07-23
A recent study demonstrates that Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) selectively suppresses triple-negative breast cancer by triggering ferroptosis through CUL3-mediated ubiquitination of MTDH. These findings establish a mechanistic basis for using Gramine as a research tool to interrogate ferroptosis pathways in aggressive cancer subtypes.
-
MLN4924: NEDD8-Activating Enzyme Inhibitor for Cancer Models
2026-07-23
MLN4924 is a highly selective NEDD8-activating enzyme inhibitor, empowering cancer researchers to dissect the neddylation pathway and block cullin-RING ligase-mediated degradation with precision. Explore optimized workflows, practical troubleshooting, and cutting-edge applications that make MLN4924 from APExBIO indispensable for translational oncology.
-
Etomoxir: Strategic Insights for Translational Immunometabol
2026-07-22
This thought-leadership article unpacks the mechanistic and translational value of Etomoxir (R-(+)-Etomoxir) in immunometabolic research. We connect the dots between CPT-1 inhibition, immune modulation, and standardized whole-blood assays, offering actionable guidance and forward-looking perspectives for researchers seeking to bridge basic science and clinical innovation.
-
Gramine: Applied Ferroptosis Inducer for TNBC Research Workf
2026-07-22
Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) offers researchers a validated, high-purity tool to induce ferroptosis in triple-negative breast cancer (TNBC) models. This guide translates recent mechanistic breakthroughs into actionable workflows, protocol enhancements, and expert troubleshooting for reproducible cancer biology research.
-
WST-8 Glucose Uptake Assay Kit: Decoding Autophagy and Insul
2026-07-21
Explore how the WST-8 Glucose Uptake Assay Kit enables precise, non-radioactive glucose uptake quantification while illuminating the intersection of autophagy and insulin resistance in metabolic research. This article uniquely connects biochemical assay optimization to cutting-edge discoveries in NAFLD pathogenesis.